Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialEugenio Mercuri, A. Nascimento, Juan J. Vílchez et al.|The Lancet Neurology|2024Cited by 128
Safety, Tolerability, and Pharmacokinetics of SMT C1100, a 2-Arylbenzoxazole Utrophin Modulator, following Single- and Multiple-Dose Administration to Pediatric Patients with Duchenne Muscular DystrophyValeria Ricotti, Jonathon M. Tinsley, Stefan Spinty et al.|PLoS ONE|2016Cited by 53
A Phase 1b Trial to Assess the Pharmacokinetics of Ezutromid in Pediatric Duchenne Muscular Dystrophy Patients on a Balanced DietFrancesco Muntoni, Jonathon M. Tinsley, Imelda Hughes et al.|Clinical Pharmacology in Drug Development|2019Cited by 40
Multidisciplinary Care for Moebius Syndrome and Related Disorders: Building a Management ProtocolAmar Odedra, Adel Fattah, Wendy Blumenow et al.|Journal of Clinical Medicine|2024Cited by 5
Utrophin modulators to treat Duchenne muscular dystrophy (DMD): Phase 1b Clinical Trial Results of SMT C1100 (P2.006)Jon Tinsley, Kay E. Davies, Francesco Muntoni et al.|Neurology|2015Cited by 1